11-36081659-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_174902.4(LDLRAD3):āc.200C>Gā(p.Ala67Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_174902.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDLRAD3 | NM_174902.4 | c.200C>G | p.Ala67Gly | missense_variant | 3/6 | ENST00000315571.6 | NP_777562.1 | |
LDLRAD3 | NM_001304263.2 | c.53C>G | p.Ala18Gly | missense_variant | 2/5 | NP_001291192.1 | ||
LDLRAD3 | NM_001304264.2 | c.-280C>G | 5_prime_UTR_variant | 2/6 | NP_001291193.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LDLRAD3 | ENST00000315571.6 | c.200C>G | p.Ala67Gly | missense_variant | 3/6 | 1 | NM_174902.4 | ENSP00000318607 | P1 | |
LDLRAD3 | ENST00000528989.5 | c.53C>G | p.Ala18Gly | missense_variant | 2/5 | 1 | ENSP00000433954 | |||
LDLRAD3 | ENST00000524419.5 | c.53C>G | p.Ala18Gly | missense_variant | 2/6 | 5 | ENSP00000434313 | |||
LDLRAD3 | ENST00000532490.1 | n.154C>G | non_coding_transcript_exon_variant | 3/5 | 4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461888Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 727246
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2024 | The c.200C>G (p.A67G) alteration is located in exon 3 (coding exon 3) of the LDLRAD3 gene. This alteration results from a C to G substitution at nucleotide position 200, causing the alanine (A) at amino acid position 67 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.